Emma Behan, David Elsea, Ibrahim M. Abbass, Fadoua El Moustaid, An Pregenzer, Maja Alexandra Cruz, Sarika Ogale, Reva K. Basho. "Estimated clinical benefits of timely biomarker testing and matched therapy in HR+/HER2– metastatic breast cancer in the United States: A population model.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e13049